This is good news for existing Alzheimer’s patients, and the over 1,200 new patients, on average, being diagnosed with Alzheimer’s each day…
Several new companies have received approval from the FDA to sell the generic.
- Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.
- Teva Announces Launch of Generic Aricept in the United States
- Actavis’ generic Aricept gets FDA nod